ArticleVeterinary pathology2025
Feline eosinophilic sclerosing fibroplasia associated with T-/natural killer-cell lymphoma.
Article in Veterinary pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The oncogenome of the domestic cat.Science (New York, N.Y.) · 2026Article
- Obstructive colonic FGESF associated with feline infectious peritonitis in a cat: a case report.BMC veterinary research · 2026Article
- A case of feline gastrointestinal eosinophilic sclerosing fibroplasia extending to the liver and jejunal lymph nodes.The Canadian veterinary journal = La revue veterinaire canadienne · 2025Article
- A Case of Feline Eosinophilic Sclerosing Fibroplasia Associated with a Duodenal Mass Responsive to Exclusive Glucocorticoid Therapy.Animals : an open access journal from MDPI · 2025Article
- Bicavitary involvement of feline eosinophilic sclerosing fibroplasia with intralesional methicillin-resistantJFMS open reportsArticle
- Nasopharyngeal eosinophilic sclerosing fibroplasia in a 15-year-old cat: expanding the anatomical and age spectrum of the disease.JFMS open reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Feline eosinophilic sclerosing fibroplasia (FESF) is a proliferative, inflammatory disease of the gastrointestinal tract and other sites, uncommonly diagnosed in the cat. This entity of uncertain etiology typically presents as a progressive mass lesion, mimicking a neoplastic process. In this case series, we present 17 cases of FESF associated with intralesional lymphoma. Histologic and immunohistochemical characterization of this unique lymphoma revealed that the neoplastic lymphocytes were immunopositive for CD56 and/ or CD3, suggesting a natural killer cell, natural killer T-cell, or T-cell origin. This case series represents the first description of this lymphoma subtype, for which the term eosinophilic sclerosing lymphoma is proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.